Single center experience with alpelisib-fulvestrant in heavily pretreated women with HR(+), HER-2 (-) metastatic breast cancer.-MedSci.cn

Single center experience with alpelisib-fulvestrant in heavily pretreated women with HR(+), HER-2 (-) metastatic breast cancer.

Tryfonopoulos, D; Tzouda, V; Zouki, D; Kyriakidou, A; Sarris, E; Grivas, A; Gouveris, P; Papaxoinis, G; Demiri, SG

JOURNAL OF CLINICAL ONCOLOGY, 2022; 40 (16):

科室
- - 订阅+
  - 更多科室
工具
服务